全文获取类型
收费全文 | 5702篇 |
免费 | 662篇 |
国内免费 | 55篇 |
专业分类
耳鼻咽喉 | 14篇 |
儿科学 | 265篇 |
妇产科学 | 267篇 |
基础医学 | 875篇 |
口腔科学 | 135篇 |
临床医学 | 588篇 |
内科学 | 1002篇 |
皮肤病学 | 167篇 |
神经病学 | 527篇 |
特种医学 | 262篇 |
外科学 | 637篇 |
综合类 | 152篇 |
一般理论 | 5篇 |
预防医学 | 648篇 |
眼科学 | 151篇 |
药学 | 355篇 |
1篇 | |
中国医学 | 24篇 |
肿瘤学 | 344篇 |
出版年
2021年 | 68篇 |
2020年 | 37篇 |
2019年 | 65篇 |
2018年 | 92篇 |
2017年 | 87篇 |
2016年 | 94篇 |
2015年 | 85篇 |
2014年 | 121篇 |
2013年 | 162篇 |
2012年 | 205篇 |
2011年 | 206篇 |
2010年 | 161篇 |
2009年 | 173篇 |
2008年 | 212篇 |
2007年 | 268篇 |
2006年 | 246篇 |
2005年 | 199篇 |
2004年 | 192篇 |
2003年 | 192篇 |
2002年 | 208篇 |
2001年 | 199篇 |
2000年 | 197篇 |
1999年 | 192篇 |
1998年 | 139篇 |
1997年 | 128篇 |
1996年 | 111篇 |
1995年 | 91篇 |
1994年 | 82篇 |
1993年 | 98篇 |
1992年 | 140篇 |
1991年 | 121篇 |
1990年 | 132篇 |
1989年 | 140篇 |
1988年 | 116篇 |
1987年 | 135篇 |
1986年 | 114篇 |
1985年 | 117篇 |
1984年 | 98篇 |
1983年 | 88篇 |
1982年 | 64篇 |
1981年 | 44篇 |
1980年 | 59篇 |
1979年 | 68篇 |
1978年 | 57篇 |
1977年 | 57篇 |
1976年 | 49篇 |
1975年 | 46篇 |
1974年 | 53篇 |
1973年 | 53篇 |
1972年 | 46篇 |
排序方式: 共有6419条查询结果,搜索用时 15 毫秒
101.
Non-invasive detection of fecal protein kinase C betaII and zeta messenger RNA: putative biomarkers for colon cancer 总被引:2,自引:0,他引:2
Davidson LA; Aymond CM; Jiang YH; Turner ND; Lupton JR; Chapkin RS 《Carcinogenesis》1998,19(2):253-257
We have developed a non-invasive method utilizing feces, containing
sloughed colonocytes, as a sensitive technique for detecting diagnostic
colonic biomarkers. In this study, we used the rat colon carcinogenesis
model to determine if changes in fecal protein kinase C (PKC) expression
have predictive value in monitoring the neoplastic process. Weanling rats
were injected with saline or azoxymethane (AOM) and 36 weeks later fecal
samples and mucosa were collected, poly A+ RNA isolated, and quantitative
RT-PCR performed using primers to PKC betaII and zeta. Fecal PKC betaII and
zeta mRNA levels were altered by the presence of a tumor, with
tumor-bearing animals having a 3-fold higher (P < 0.05) PKC betaII
expression as compared with animals without tumors. In addition,
AOM-injection increased mucosal PKC betaII mRNA expression compared with
saline controls. No effect of tumor incidence on mucosal PKC betaII
expression was observed. In contrast, fecal PKC zeta expression was
2.5-fold lower (P < 0.05) in animals injected with azoxymethane versus
saline. Since tumor incidence exerts a reciprocal effect on fecal PKC
betaII and zeta mRNA expression, data were also expressed as the ratio
between PKC betaII and zeta. The isozyme ratio was strongly related to
tumor incidence, i.e. ratio for animals with tumors was 2.18 +/- 1.25,
animals without tumors was 0.50 +/- 0.16, P = 0.025. We demonstrate that
the expression of fecal PKC betaII and zeta may serve as a noninvasive
marker for development of colon tumors. A sensitive technique for the
detection of colon cancer is of importance since early diagnosis can
substantially reduce mortality.
相似文献
102.
Christopher J. Twelves Nicola A. Dobbs Helen C. Gillies Christopher A. James Robert D. Rubens Peter G. Harper 《Cancer chemotherapy and pharmacology》1998,42(3):229-234
We studied variability in doxorubicin pharmacokinetics in 24 patients with abnormal liver biochemistry tests. Blood samples
were collected after the first cycle of single-agent doxorubicin given as an i.v. bolus and plasma levels were measured by
high-performance liquid chromatography. The relationship between doxorubicin clearance (dose/AUC) and liver biochemistry tests
(AST, bilirubin, albumin, alkaline phosphatase and indocyanine green clearance) was investigated. Patients with a raised bilirubin
level had reduced doxorubicin clearance, but there was no clear relationship between the extent of this elevation and the
reduction in doxorubicin clearance. Doxorubicin clearance was lower in patients with an isolated increase in AST than in those
with normal liver biochemistry, but this difference was not statistically significant. Nevertheless, there was a significant
correlation between reduced doxorubicin clearance and both raised serum AST levels and low indocyanine green clearance. These
pharmacokinetic data suggest that current dose reductions based solely on the extent to which bilirubin is elevated may not
be optimal.
Received: 20 October 1997 / Accepted: 20 January 1998 相似文献
103.
104.
105.
106.
Community-university partnerships for research and action are at the heart of many fields in the social sciences including public health, urban planning, education, and community psychology. These partnerships involve individuals from different backgrounds and disciplines working together to address social issues of importance to the community. This article proposes an interactive and contextual model for developing and sustaining community-university partnerships. The phases in the model include gaining entry into the community, developing and sustaining a mutual collaboration (developing trust and mutual respect, establishing adequate communication, respecting human diversity, establishing a culture of learning, respecting the culture of the setting and the community, and developing an action agenda), and recognizing the benefits and outcomes of partnership work. The model also includes the potential challenges that might threaten the partnership, such as resource inequality and time commitment. 相似文献
107.
Perspectives on colorectal cancer screening: a focus group study 总被引:3,自引:0,他引:3
Vivek Goel MD MSc FRCPC Ross Gray PhD Pam Chart MD CM Marg Fitch RN PhD Fred Saibil MD FRCPC Yola Zdanowicz MA 《Health expectations》2004,7(1):51-60
Objective To assess attitudes and acceptability of Ontario consumers and doctors towards colorectal screening with faecal occult blood testing (FOBT) and colonoscopy. Design, setting and participants Focus groups with gender‐specific samples of the population, high‐risk gastroenterology patients and family doctors. Method Semi‐structured interview guides used by facilitator to lead groups through knowledge of risk factors and prevention of colorectal cancer, the screening modalities, requirements for implementing screening programmes, barriers to screening and preferences towards screening. Main findings There were low levels of knowledge about colorectal cancer and its prevention in the general population. FOBT was an acceptable screening modality, but considerable education about its use and benefits would be necessary to implement a screening programme. Colonoscopy was not perceived to be a good choice for a primary screen in the general population. The high‐risk group supported use of FOBT in the general population and emphasized the need for education. The doctors were more reluctant about screening, requesting clear guidelines. They also identified the time and resources that would be required if a screening programme were initiated. Conclusion While colorectal screening is acceptable in this sample, information and decision aids are required to enable consumers and providers to make effective decisions. Implementation of colorectal screening programmes requires substantial educational efforts for both consumers and doctors. 相似文献
108.
R M Rudd N H Gower S G Spiro T G Eisen P G Harper J A H Littler M Hatton P W M Johnson W M C Martin E M Rankin L E James W M Gregory W Qian S M Lee 《Journal of clinical oncology》2005,23(1):142-153
PURPOSE: This phase III randomized trial compared two chemotherapy regimens, gemcitabine plus carboplatin and mitomycin, ifosfamide, and cisplatin, in chemotherapy-naive patients with advanced non-small-cell lung cancer (NSCLC). The regimens were compared with regard to effects on survival, response rates, toxicity, and quality of life. PATIENTS AND METHODS: Eligible patients had previously untreated stage IIIB or IV NSCLC suitable for cisplatin-based chemotherapy. Randomly assigned patients were to receive four cycles, each at 3-week intervals, of carboplatin area under the curve of 5 on day 1 plus gemcitabine 1,200 mg/m(2) on days 1 and 8 (GCa) or mitomycin 6 mg/m(2), ifosfamide 3g/m(2), and cisplatin 50 mg/m(2) on day 1 (MIC). RESULTS: Between February 1999 and August 2001, 422 patients (GCa, n = 212; MIC, n = 210) were randomly assigned in the United Kingdom. The majority of patients received the intended four cycles (GCa, 64%; MIC, 61%). There was a significant survival advantage for GCa compared with MIC (hazard ratio, 0.76; 95% CI, 0.61 to 0. 93; P = .008). Median survival was 10 months with GCa and 7.6 months with MIC (difference, 2.4 months; 95% CI, 1.0 to 4.0), and 1-year survival was 40% with GCa and 30% with MIC (difference, 10%; 95% CI, 3% to 18%). Overall response rates were similar (42% for GCa v 41% for MIC; P = .84). More thrombocytopenia occurred with GCa (P = .03), but this was not associated with increased hospital admission or fatality. GCa caused less nausea, vomiting, constipation, and alopecia and was associated with fewer admissions for administration and better quality of life. CONCLUSION: In patients with advanced NSCLC, GCa chemotherapy was shown to be a better-tolerated treatment that conferred a survival advantage over MIC. 相似文献
109.
110.
Different theories have evolved to explain the pathogenesis and the cell of origin of intraneural ganglion cysts. Reportedly only three cases of intraneural ganglion of the tibial nerve have been located within the popliteal fossa, and all of these were thought to arise within the nerve. The authors report a case of a recurrent tibial intraneural ganglion in which a connection to the proximal tibiofibular joint was demonstrated on magnetic resonance (MR) images and at surgery. Surgical ligation of the articular branch and evacuation of the cyst led to symptomatic relief, and an MR image obtained 1 year after surgery documented no recurrence. This case reinforces the fact that surgeons need to consider and search for an articular connection in all cases of intraneural ganglia, especially in those that have recurred. 相似文献